Resolve Biosciences builds Molecular Cartography™, a high-resolution spatial-biology platform that lets researchers map RNA, protein, and tissue morphology inside intact tissue to study disease and develop precision medicines.

Founders

• Jason T. Gammack · co-founder and CEO
  Before Resolve, he was Chief Commercial Officer at Inscripta, Vice President of the Life Science Business at QIAGEN, and earlier held senior leadership roles at Ingenuity Systems, Sigma-Aldrich, Invitrogen/Life Technologies, Affymetrix, and Promega Corporation.
• Peer M. Schatz · Chairman of the Board and co-founder

Total raised

more than $100 million · as its sources put it, more than the rounds on record

Customers

VIB (Vlaams Instituut voor Biotechnologie), Novo Nordisk Foundation Center at the University of Copenhagen, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Stanford Medicine Department of Genetics, European Spatial Biology Center